Patients with locally advanced disease and M0 stage showed a trend toward better median OS when first treated with eRFA (19.7 months; 95% CI, 13.9–25.5) compared with ePDT (12.7 months; 95% CI, 8.9–16.5) but without statistical significance (p = 0.068) ( Supplemental Data 2A ).
← all excerpts
Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.
1
—
—